Encompass Health price target raised to $108 from $101 at Barclays

Barclays raised the firm’s price target on Encompass Health to $108 from $101 and keeps an Overweight rating on the shares post the Q1 report. The company reported strong discharge growth, solid pricing and well controlled costs, the analyst tells investors in a research note.